Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men With Biochemical Recurrence of Prostate Cancer

NCT06235099 is registered in ClinicalTrials.gov with Curium US LLC as lead sponsor.

NCT NCT06235099
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06235099 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 3, Multi-Center, Open-label Study to Test the Diagnostic Performance of Copper Cu 64 PSMA I&T PET/CT in Men With Biochemical Recurrence of Prostate Cancer
Lead sponsor
Curium US LLC
Phase
Phase 3
Overall status
Completed
Start date
April 1, 2024
Completion date
February 18, 2025
Enrollment
235 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

biochemical recurrence of malignant neoplasm of prostate, prostate adenocarcinoma, prostate cancer